Who owns Enlivex Ltd, from the filings themselves: stakes over 5% (Schedule 13D/G), the institutional managers reporting the stock each quarter (13F), and the funds holding it (N-PORT).
Investors crossing 5% ownership must disclose it. Schedule 13G filers certify the stake is passive; Schedule 13D is the general form for everyone else — founders, strategic holders, and activists alike. Each entry is the holder's most recent disclosure. Coverage begins with SEC's structured filings from December 18, 2024; a holder appears once they file or amend after that date.
Lind Global Asset Management XIV, LLC: 10.0% · 1,927,744 shares — Lind Partners LLC: 10.0% · 1,927,744 shares — EASTON JEFF: 10.0% · 1,927,744 shares
Armistice Capital, LLC: 5.0% · 1,178,389 shares — Steven Boyd: 5.0% · 1,178,389 shares
Every institutional manager whose latest 13F reports this stock, largest position first. "% of their portfolio" is the weight inside that manager's own book — how much conviction the position represents; "% of company" is how much of Enlivex Ltd they hold. Together these 127 managers report 59.15% of shares outstanding.
| Investor | Position value | Shares | % of their portfolio | % of company | As of |
|---|---|---|---|---|---|
| MAK CAPITAL ONE LLC | $53.8M | 33,621,487 | 7.54% | 14.16% | June 30, 2026 |
| Blackstone Inc. | $32.8M | 20,485,611 | 0.10% | 8.63% | June 30, 2026 |
125 more institutional holders behind a free account
See every manager reporting Enlivex Ltd, how much of the company they hold, and how big the position is inside their own portfolio.
Sign up freeFunds disclosing this stock in their monthly N-PORT portfolio, with the position's share of the fund's net assets. Together these 12 funds hold 1.07% of shares outstanding — counted inside the manager totals above, not on top of them, since a fund's shares also appear in its manager's 13F.
| Fund | Position value | % of net assets | % of company | As of |
|---|---|---|---|---|
| iShares Biotechnology ETF | $1.82M | 0.02% | 0.56% | March 31, 2026 |
| BlackRock Health Sciences Opportunities Portfolio | $1.25M | 0.02% | 0.31% | February 27, 2026 |
10 more funds behind a free account
See every fund holding Enlivex Ltd and what share of its net assets the position represents.
Sign up freeLoading...
